The Daily cover image

A Major Overhaul of Prescription Drug Prices

The Daily

00:00

Navigating Medicare Drug Price Negotiations

This chapter delves into the criteria and strategies for selecting prescription drugs eligible for price negotiations under Medicare, aiming to balance profitability for manufacturers with cost reductions for patients. It highlights recent legislative changes aimed at making medications more affordable, including a cap on out-of-pocket expenses for Medicare patients starting in 2025. Additionally, the discussion touches upon the potential wider impact on the pharmaceutical industry and innovation, alongside concerns from drug manufacturers regarding these new regulations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app